StypCel™ Absorbable Hemostat

100% absorbable within 7-14 days

Hemostasis in capillary, venous as well as small artery bleeding
StypCel™ works when ligation or other conventional methods are

impracticable or ineffective.

Fast hemostatic rate

pre-clinical study on livers of rabbits, result demonstrates StypCel™ hemostatic faster

more compact structure

provides StypCel™ larger contact area attaching to wound surface so as to strengthen hemostatic effect

Simple shaping

Description	Link

Medprin is short for “Medical Printing”. Medprin specializes in research, development, and manufacturing of the high-end medical devices, with successful technology transformation of Class III implantable medical devices such as ReDura™, NeoDura™, and Recranio™, etc.. Products are available in more than 70 countries and regions and have benefited more than 200,000 patients.